HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
“These 6- and 12-month data demonstrate a strong safety profile with highly effective and durable PVI achieved with the nPulse Cardiac Catheter Ablation System, suggesting that this system has the ...
Abstract: This paper proposes and demonstrates an arbitrarily tunable multi-frequency pulse modulation scheme based on an active fiber loop, which effectively suppresses the interference fading effect ...
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...
Escalating from last month’s internal warnings of rough vibes, OpenAI CEO Sam Altman has declared a company-wide “Code Red” to salvage his flagship product. As a result, the “Pulse” personal assistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results